The toxic natural product tutin causes epileptic seizures in mice by activating calcineurin

Tutin, an established toxic natural product that causes epilepsy in rodents, is often used as a tool to develop animal model of acute epileptic seizures. However, the molecular target and toxic mechanism of tutin were unclear. In this study, for the first time, we conducted experiments to clarify th...

Full description

Saved in:
Bibliographic Details
Published inSignal transduction and targeted therapy Vol. 8; no. 1; p. 101
Main Authors Han, Qing-Tong, Yang, Wan-Qi, Zang, Caixia, Zhou, Linchao, Zhang, Chong-Jing, Bao, Xiuqi, Cai, Jie, Li, Fangfei, Shi, Qinyan, Wang, Xiao-Liang, Qu, Jing, Zhang, Dan, Yu, Shi-Shan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 10.03.2023
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tutin, an established toxic natural product that causes epilepsy in rodents, is often used as a tool to develop animal model of acute epileptic seizures. However, the molecular target and toxic mechanism of tutin were unclear. In this study, for the first time, we conducted experiments to clarify the targets in tutin-induced epilepsy using thermal proteome profiling. Our studies showed that calcineurin (CN) was a target of tutin, and that tutin activated CN, leading to seizures. Binding site studies further established that tutin bound within the active site of CN catalytic subunit. CN inhibitor and calcineurin A (CNA) knockdown experiments in vivo proved that tutin induced epilepsy by activating CN, and produced obvious nerve damage. Together, these findings revealed that tutin caused epileptic seizures by activating CN. Moreover, further mechanism studies found that N -methyl- D -aspartate (NMDA) receptors, gamma-aminobutyric acid (GABA) receptors and voltage- and Ca 2+ - activated K + (BK) channels might be involved in related signaling pathways. Our study fully explains the convulsive mechanism of tutin, which provides new ideas for epilepsy treatment and drug development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2059-3635
2095-9907
2059-3635
DOI:10.1038/s41392-023-01312-y